INTRODUCTION
The pathogenesis of biomaterial-associated infections (BAI) is poorly understood. It has been suggested that, besides adherence of bacteria to biomaterials, alterations in the host inflammatory response in the vicinity of an implanted biomaterial play a role [1] . Especially deficiencies in phagocytic and intracellular killing functions of polymorphonuclear cells (PMNs) have been studied extensively in this context [1] [2] [3] . Recently, also deficiencies in mononuclear phagocyte function have been reported [4] . In clinical series as well as in experimental animal models MHC class II antigen (la) expression on mononuclear cells, which is associated with low lysosomal activity, was suppressed around infected biomaterials [4] . Suppressed la expression may result in decreased intracellular bacterial killing. Recently, we reported that intracellular survival of Staphylococcus epidermidis in macrophages occurred around four different biomaterials, and suggested this to be a pivotal process in the pathogenesis of BAI [5] .
Hence, local host defense is compromised due to the presence of the implanted biomaterials, resulting in macrophage deactivation and subsequent deficient intracellular killing. Host defense against invading pathogens is orchestrated by cytokines, of which interferon (IFN)-y plays a complex and central role [6] . IFN-y has many biological activities, including induction of MHC class II proteins on phagocytic cells, activation of mononuclear phagocytes, and regulation of the humoral immune response [6] .
We speculated that reversal of macrophage deactivation, in the vicinity of an implanted biomaterial, might increase the antimicrobial efficacy of the immune system, resulting in a better clearance of bacteria. Therefore, we tested whether subcutaneous administration of IFN-y could reduce the susceptibility to infection in a mouse model of biomaterial-associated S. epidermidis infection.
MATERIAL AND METHODS
Animals. In total 26 specified pathogen free female C57BL6 mice, 6-8 weeks old and weighing 15-20 g were used. All animals were housed in individual cages, in a pathogen-free environment and provided with sterile food and water.
Catheter segments. Catheters of polyvinylpyrrolidone-coated polyamide with a diameter of 2.5 mm and a wall thickness of 0.6 mm were manufactured at the Center for Biomaterials Research, University of Maastricht, the Netherlands. One cm long segments, cut from either catheter under aseptic conditions in a laminar flow cabinet were stored in sterile petri dishes.
Preparation of Staphylococcus epidermidis inocula.
The slime producing S. epidermidis RP62a (ATCC 35984) strain was used as the challenge organism [7] . MIC values (ug/mL) of strain RP62a determined by standard Etest were for rifampicin <0.016, teicoplanin 0.19, gentamicin 256, minocyclin <0.016 and vancomycin 1.5.
Antibiotic susceptibilities were used to confirm the identity of colonies cultured from catheter segments and tissue homogenates (see below). An inoculum of 10 6 cfu / 25 uL was prepared by growing S. epidermidis to midlogarithmic phase at 37°C in Trypticase Soy Broth (TSB; Difco, Detroit, MI) and diluting the suspension with pyrogen-free isotonic saline, based on an established relationship between bacterial concentration and optical density at 620 nm. The injection of this inoculum along implanted catheter segments reproducibly induced a BAI in this mouse model [5] .
Induction of a biomaterial-associated infection in mice.
Mice were anesthetized with FFM-mix (hypnorm® 1 mL, midazalam® 1 mL distilled water 2 mL; 0.07 mL/lOg body weight) administered intraperitoneally. Surgery was performed in a laminar flow cabinet. The back of the mice was shaved and prepared with 2% Chlorhexidine.
On each side an incision (0.3 cm) was made 0.5 cm lateral to the spine. Subsequently catheter segments with a length of 1 cm were inserted subcutaneously on both sides. The incisions were closed with a single 0/6 vicryl stitch. Subsequently, the bacterial inoculum was injected subcutaneously along the inserted segments.
Subcutaneous administration of IFN-y.
Mice were divided into four groups. The first group (IFN1; n=6) received subcutaneous injections of 25uL pyrogen-free isotonic saline containing 25,000 IU carrier-free recombinant murine-IFN-y (rmlFN-y; R&D systems, Minneapolis, MN), 3 times weekly, the second group (IFN2; n=8), 10,000 IU rmIFN-y, 3 times in 2 weeks, the third group (saline-control; n=6) saline only, 3 times weekly, and the fourth group (control; n=6), did not receive any injection.
Sample collection. Fourteen days after implantation mice were anaesthetised with FFM-mix, and terminated by cardiac puncture. Terminated mice were placed in a laminar flow cabinet and fixed on a sterile polypropylene plate. A dorsal midline incision was made from the cervical to the lumbal area. Subsequently, the skin and subcutaneous tissue were separated from the muscle fascia, up to the flank on both sides. The implantation sites were inspected for purulence and standardized biopsies (<| ) 12mm) were taken from the implantation sites using a specially developed tissue sampler. Each single biopsy included skin, subcutaneous tissue and the inserted segment.
The right side biopsy from each mouse was placed in 10% buffered formaldehyde (pH 7.3) for histological examination. From the left side biopsy, the catheter segment was separated from the tissue, washed twice with phosphate buffered saline (PBS) and placed in a sterile tube containing 1 mL of PBS. Each tissue sample was placed in a tube, weighed, and a volume of pyrogen-free isotonic saline corresponding to 4 times the weight was added. The weight of the tissue samples varied between 125 and 160 mg.
Histological examination. After fixation in formaldehyde, the biopsies were embedded in plastic, methylmethacrylaat / butylmethacrylaat (Merck Schuchart, Hohenbrunn, Germany), sectioned, and stained with hematoxylin-eosin (HE). Slides were examined for 5 histological features characteristic for tissue reactions after implantation of a foreign body [8] . 
Data analysis.
All values are expressed as Mean ± Std.Error. Two sample comparisons were made by analysis of variance (ANOVA). The significance of differences between the frequencies of categorical variables was determined using the x-square or Fisher's exact tests. P< 0.05 was considered to be statistically significant.
RESULTS
Infection associated with subcutaneously implanted catheter segment. At 14 d after challenge all mice were killed. No purulence or signs of inflammation were observed macroscopically around any of the catheter segments in any group. In the control and saline-control groups, all 6 segments (773+1,046 and 805+1,051 cfu / cm, respectively), and all 6 tissue homogenates (3,513+1,514 and 2,552+1,771 cfu / biopsy, respectively), were culture-positive for S. epidermidis ( figure 1 ). In contrast, in the IFN1 and IFN2 groups significantly less segments (2 out of 6 and 3 out of 8, respectively; both PO.05 vs. either control group), and significantly less tissue homogenates were culture-positive (1 out of 6 and 2 out of 8, respectively; both P<0.05 vs. either control group; figure 1 ). In the 3 out of 8 segments that were culture positive in the IFN2 group, the number of cultured cfu (121+80) was significantly lower (P<0.01) than in the non-injected and saline-control-groups (figure 1). All cultured colonies had the same antibiogram as S. epidermidis RP62a. Hence, mice treated with IFN-y were less susceptible to BAI due to S. epidermidis. 
Histological examination of the inflammatory and foreign body response.
Around the catheter segments in the control and saline-control groups a moderate mononuclear inflammation and fibrosis was observed. In addition, a thick layer containing giant cells bordering the catheter, associated with a granuloma was observed (figure 2). In contrast, in the IFN1 and IFN2 groups no layer containing giant cells bordering the catheter-tissue interface, nor an associated granuloma were observed. The tissue surrounding the catheter segments in the IFN1 and IFN2 group was moderately inflamed with mainly mononuclear cells.
Intracellular persistence ofS. epidermidis in macrophages.
In the control and saline-control groups large numbers of macrophages containing gram-positive cocci were observed in the granulomatous tissue surrounding the implanted catheter segment (figure 2). In contrast, in the IFN1 and IFN2 group neither intracellular persistence nor extracellular persistence of gram-positive cocci was observed around implanted segments ( figure 2 ).
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DISCUSSION
Recently, we suggested intracellullar survival of bacteria in macrophages to be a pivotal process in the pathogenesis of BAI [5] . Since IFN-y activates mononuclear cell functions, in the present study we sought to determine whether subcutaneous administration of IFN-y reduces the susceptibility to S. epidermidis infection associated with an implanted biomaterial. We found that mice injected with either a high or low dose of IFN-y are less susceptible to BAL The abundant amounts of intracellularly persisting gram-positive cocci observed in the control mice were absent in the IFN-y treated mice.
Deficiencies in host defense due to an implanted biomaterial have often been suggested. Only in a few studies it was attempted to reverse this defect by immunomodulation of the host response. Rozalska et al demonstrated that granulocyte-macrophage colony-stimulating factor-coated implants reduced bacterial survival around an infected biomaterial in neutropenic mice, although abscess formation was not prevented [9] . Henke observed that suppressed MHC class II antigen expression in macrophages around infected biomaterials was associated with enhanced prostagandin E2 (PGE2) and IL-1 production [4] . Blocking the enhanced PGE2 and IL-1 production around implanted biomaterials, with indomethacin and anti-IL-1, respectively, increased the bacterial clearance around the infected biomaterial [4] . We speculated that administration of IFN-y might prevent a BAI, since we found that S. epidermidis was able to survive in tissue macrophages surrounding an implant. In this respect, it should be noted that rapid IFN-y production is a key factor in resistance of the host to intracellular bacterial pathogens. Mice with depleted IFN-y activity are highly susceptible to intracellular pathogens [6, 10, 11] . Similarly, patients with a disrupted IFN-y receptor are highly susceptible to weakly pathogenic mycobacterial species [12] . Conversely, administration of IFN-y to mononuclear cells infected with an intracellular pathogen promotes intracellular killing [13] . In addition, monocyte deactivation in septic patients could be restored by IFN-y treatment, resulting in decreased susceptibility to infection [14] . In the present model of BAI, which shows characteristics of an intracellular bacterial infection, deficient intracellular killing of macrophages, was reversed by scheduled subcutaneous injections of IFN-y.
Histologically, intracellular bacterial infections are associated with granulomatous tissue, characterized by macrophage-epitheloid cells and foreign body giant cells [15] . In a normal foreign body reaction a very slight granulomatous tissue reaction is observed [8] , but not as strong as observed around implanted catheter segments in control mice. Granulomatous inflammation is a mechanism of the host to deal with indigestible substances and intracellular pathogens evading intracellullar killing [15] . However, when mice were injected subcutaneously with IFN-y, histologically neither granulomatous inflammation nor associated intracellular persistence was seen in tissue bordering the implanted biomaterial. This finding further indicates that the local acquired immune deficiency due the presence of the implanted biomaterial was reversed after administration of IFN-y.
In conclusion, subcutaneous injections of IFN-y prevented intracellular persistence of S. epidermidis in the vicinity of an implanted biomaterial in mice. IFN-y may therefore be beneficial in the prevention of BAI.
